David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Consumer Discretionary | 9.92% |
| 3 | Healthcare | 7.34% |
| 4 | Financials | 7.06% |
| 5 | Communication Services | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
State Street SPDR S&P Regional Banking ETF
KRE
$4.06B
| $47.3M | 0.04% |
+698,781
| New | +$44.9M |
|
502
Nike
NKE
$60.5B
| $47.1M | 0.04% |
324,642
-601,400
| -65% | -$98.1M |
|
503
CALL
Okta
OKTA
$22.8B
| $47.1M | 0.04% |
198,600
+45,300
| +30% | +$11.2M |
|
504
PUT
Bristol-Myers Squibb
BMY
$137B
| $47M | 0.04% |
793,900
+260,800
| +49% | +$17.2M |
|
505
PUT
RingCentral
RNG
$5.6B
| $46.9M | 0.04% |
215,800
+78,200
| +57% | +$19.8M |
|
506
SolarEdge
SEDG
$1.85B
| $46.7M | 0.04% |
176,258
+118,529
| +205% | +$32.3M |
|
507
Magna International
MGA
$18.1B
| $46.7M | 0.04% |
621,748
+515,182
| +483% | +$42.4M |
|
508
TE Connectivity
TEL
$58.6B
| $46.7M | 0.04% |
340,302
-1,678
| -0.5% | -$242K |
|
|
XLRN
509
DELISTED
Acceleron Pharma
XLRN
| $46.7M | 0.04% |
271,291
+201,795
| +290% | +$26.4M |
|
510
Paycom
PAYC
$10.3B
| $46.7M | 0.04% |
94,144
-14,710
| -14% | -$6.56M |
|
|
SGEN
511
DELISTED
Seagen Inc. Common Stock
SGEN
| $46.5M | 0.04% |
273,656
-115,798
| -30% | -$18M |
|
512
GoPro
GPRO
$111M
| $46.4M | 0.04% |
4,957,692
-540,073
| -10% | -$5.46M |
|
513
Becton Dickinson
BDX
$52B
| $46.3M | 0.04% |
192,934
-27,877
| -13% | -$6.84M |
|
514
Appian
APPN
$2.81B
| $46.2M | 0.04% |
499,716
-161,833
| -24% | -$17.9M |
|
515
CALL
BILL Holdings
BILL
$4.8B
| $45.9M | 0.04% |
171,800
+124,500
| +263% | +$28.7M |
|
516
Flex
FLEX
$39.4B
| $45.6M | 0.04% |
3,422,309
-432,958
| -11% | -$5.82M |
|
517
PUT
Freeport-McMoran
FCX
$112B
| $45.5M | 0.04% |
1,398,300
-256,000
| -15% | -$9.01M |
|
518
LyondellBasell Industries
LYB
$21.1B
| $45.5M | 0.04% |
484,302
+463,846
| +2,268% | +$45.5M |
|
519
Teladoc Health
TDOC
$1.13B
| $45.4M | 0.04% |
358,030
+205,527
| +135% | +$29.9M |
|
520
PUT
Boston Beer
SAM
$1.95B
| $44.9M | 0.04% |
88,000
+48,000
| +120% | +$32.6M |
|
521
PUT
Charter Communications
CHTR
$17.9B
| $44.8M | 0.04% |
61,600
-4,000
| -6% | -$3.03M |
|
522
Labcorp
LH
$27.5B
| $44.8M | 0.04% |
185,304
-38,533
| -17% | -$9.71M |
|
523
DaVita
DVA
$11.3B
| $44.6M | 0.04% |
384,041
+207,096
| +117% | +$25.9M |
|
524
PTC Therapeutics
PTCT
$5.93B
| $44.6M | 0.04% |
1,199,533
-10,526
| -0.9% | -$432K |
|
525
PUT
Johnson & Johnson
JNJ
$658B
| $44.3M | 0.04% |
274,200
-71,600
| -21% | -$12.2M |
|
Similar funds
David Shaw's Q3 2021 Portfolio in Review
As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Sea Limited worth $206M.
- David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- David Shaw opened 915 new positions and closed 695 in Q3 2021.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.